We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
17
2 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1949
Completed
8
47.1%
Not yet recruiting
2
11.8%
Recruiting
6
35.3%
Unknown
1
5.9%
No approval data available
- Toro Neurovascular received FDA 510(k) clearance for its Toro 88 Superbore Catheter, marking the company's first proprietary neurovascular access catheter platform designed for modern stroke interventions. - Radical Catheter Technologies obtained FDA clearance for its 6F neurovascular catheter, expanding therapeutic options particularly for middle-meningeal artery embolization and radial access procedures. - Both catheters feature innovative engineering solutions to address physician-identified performance gaps in complex neurovascular procedures requiring enhanced support, trackability, and stability. - The clearances represent significant milestones for advancing stroke care and complex cerebrovascular interventions through next-generation catheter technology.
